An alternative approach towards novel heterocycle-fused 1, 4-diazepin-2-ones by an aromatic amidation protocol

Tetrahedron

Volumn 59, Issue 36, 2003, Pages 7103-7110

  Correa, Arkaitz ^a   Herrero, M Teresa ^a   Tellitu, Imanol ^a   Domínguez, Esther ^a   Moreno, Isabel ^a   SanMartin, Raúl ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Cyclizations; Diazepin 2 ones; Heterocycles; Hypervalent iodine; N acylnitrenium

Indexed keywords

3 (4 ETHOXYCARBONYL) 1 METHOXY 3 METHYL 1,3,4,5 TETRAHYDRO 2H 1,4 THIENO[3,2 F]DIAZEPIN 2 ONE; 4 ETHOXYCARBONYL 1 METHOXY 1,3,4,5 TETRAHYDRO 2H 1,4 THIENO[3,2 F]DIAZEPIN 2 ONE; 4 ETHOXYCARBONYL 1 METHOXY 1,3,4,5 TETRAHYDRO 2H [1,4]BENZODIAZEPIN 2 ONE; 4 ETHOXYCARBONYL 1 METHOXY 3 METHYL 1,3,4,5 TETRAHYDRO 2H [1,4]BENZODIAZEPIN 2 ONE; 4 ETHOXYCARBONYL 1 METHOXY N' METHYL 1,3,4,5 TETRAHYDRO 2H 1,4 PYRROLO[2,3 F]DIAZEPIN 2 ONE; ACETIC ACID DERIVATIVE; ALANINE; AMIDE; AMINO ACID; DIAZEPINE DERIVATIVE; GLYCINE; ION; METHOXYAMIDE; N ACYLNITRENIUM ION; PHENYLIODINE BIS(TRIFLUOROACETATE); UNCLASSIFIED DRUG;

AMIDATION; ARTICLE; CYCLIZATION; DRUG PURIFICATION; DRUG SYNTHESIS; ENANTIOMER; METHODOLOGY; MOLECULAR MECHANICS; OPTICS; PRIORITY JOURNAL;

EID: 0042020360     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(03)01123-2     Document Type: Article

References (53)

1. For general reviews on polyvalent iodine compounds, see: (a) Varvoglis A. Chem. Soc. Rev. 10:1981;377-407 (b) Moriarty R.M., Vaid R.K. Synthesis. 1990;431-447 (c) Varvoglis A. The Organic Chemistry of Polycoordinated Iodine. 1992;VCH, New York, (d) Stang P.J., Zhdankin V.V. Chem. Rev. 96:1996;1123-1178 (e) Varvoglis A. Hypervalent Iodine in Organic Synthesis. 1997;Academic, San Diego, (f) Kitamura T., Fujiwara Y. Org. Prep. Proced. Int. 29:1997;409-458 (g) Varvoglis A. Tetrahedron. 53:1997;1179-1255 (h) Wirth T., Hirt U.H. Synthesis. 1999;1271-1287 (i) Ochiai M. Chem. Hypervalent. Compd. 1999;359-387 (j) Koser G.F. Aldrichim.d Acta. 34:2001;89-102 (k) Zhdankin V.V., Stang P.J. Chem. Rev. 102:2002;2523-2584.
2. For general reviews on polyvalent iodine compounds, see: (a) Varvoglis A. Chem. Soc. Rev. 10:1981;377-407 (b) Moriarty R.M., Vaid R.K. Synthesis. 1990;431-447 (c) Varvoglis A. The Organic Chemistry of Polycoordinated Iodine. 1992;VCH, New York, (d) Stang P.J., Zhdankin V.V. Chem. Rev. 96:1996;1123-1178 (e) Varvoglis A. Hypervalent Iodine in Organic Synthesis. 1997;Academic, San Diego, (f) Kitamura T., Fujiwara Y. Org. Prep. Proced. Int. 29:1997;409-458 (g) Varvoglis A. Tetrahedron. 53:1997;1179-1255 (h) Wirth T., Hirt U.H. Synthesis. 1999;1271-1287 (i) Ochiai M. Chem. Hypervalent. Compd. 1999;359-387 (j) Koser G.F. Aldrichim.d Acta. 34:2001;89-102 (k) Zhdankin V.V., Stang P.J. Chem. Rev. 102:2002;2523-2584.
3. For general reviews on polyvalent iodine compounds, see: (a) Varvoglis A. Chem. Soc. Rev. 10:1981;377-407 (b) Moriarty R.M., Vaid R.K. Synthesis. 1990;431-447 (c) Varvoglis A. The Organic Chemistry of Polycoordinated Iodine. 1992;VCH, New York, (d) Stang P.J., Zhdankin V.V. Chem. Rev. 96:1996;1123-1178 (e) Varvoglis A. Hypervalent Iodine in Organic Synthesis. 1997;Academic, San Diego, (f) Kitamura T., Fujiwara Y. Org. Prep. Proced. Int. 29:1997;409-458 (g) Varvoglis A. Tetrahedron. 53:1997;1179-1255 (h) Wirth T., Hirt U.H. Synthesis. 1999;1271-1287 (i) Ochiai M. Chem. Hypervalent. Compd. 1999;359-387 (j) Koser G.F. Aldrichim.d Acta. 34:2001;89-102 (k) Zhdankin V.V., Stang P.J. Chem. Rev. 102:2002;2523-2584.
4. For general reviews on polyvalent iodine compounds, see: (a) Varvoglis A. Chem. Soc. Rev. 10:1981;377-407 (b) Moriarty R.M., Vaid R.K. Synthesis. 1990;431-447 (c) Varvoglis A. The Organic Chemistry of Polycoordinated Iodine. 1992;VCH, New York, (d) Stang P.J., Zhdankin V.V. Chem. Rev. 96:1996;1123-1178 (e) Varvoglis A. Hypervalent Iodine in Organic Synthesis. 1997;Academic, San Diego, (f) Kitamura T., Fujiwara Y. Org. Prep. Proced. Int. 29:1997;409-458 (g) Varvoglis A. Tetrahedron. 53:1997;1179-1255 (h) Wirth T., Hirt U.H. Synthesis. 1999;1271-1287 (i) Ochiai M. Chem. Hypervalent. Compd. 1999;359-387 (j) Koser G.F. Aldrichim.d Acta. 34:2001;89-102 (k) Zhdankin V.V., Stang P.J. Chem. Rev. 102:2002;2523-2584.
5. For general reviews on polyvalent iodine compounds, see: (a) Varvoglis A. Chem. Soc. Rev. 10:1981;377-407 (b) Moriarty R.M., Vaid R.K. Synthesis. 1990;431-447 (c) Varvoglis A. The Organic Chemistry of Polycoordinated Iodine. 1992;VCH, New York, (d) Stang P.J., Zhdankin V.V. Chem. Rev. 96:1996;1123-1178 (e) Varvoglis A. Hypervalent Iodine in Organic Synthesis. 1997;Academic, San Diego, (f) Kitamura T., Fujiwara Y. Org. Prep. Proced. Int. 29:1997;409-458 (g) Varvoglis A. Tetrahedron. 53:1997;1179-1255 (h) Wirth T., Hirt U.H. Synthesis. 1999;1271-1287 (i) Ochiai M. Chem. Hypervalent. Compd. 1999;359-387 (j) Koser G.F. Aldrichim.d Acta. 34:2001;89-102 (k) Zhdankin V.V., Stang P.J. Chem. Rev. 102:2002;2523-2584.
6. For general reviews on polyvalent iodine compounds, see: (a) Varvoglis A. Chem. Soc. Rev. 10:1981;377-407 (b) Moriarty R.M., Vaid R.K. Synthesis. 1990;431-447 (c) Varvoglis A. The Organic Chemistry of Polycoordinated Iodine. 1992;VCH, New York, (d) Stang P.J., Zhdankin V.V. Chem. Rev. 96:1996;1123-1178 (e) Varvoglis A. Hypervalent Iodine in Organic Synthesis. 1997;Academic, San Diego, (f) Kitamura T., Fujiwara Y. Org. Prep. Proced. Int. 29:1997;409-458 (g) Varvoglis A. Tetrahedron. 53:1997;1179-1255 (h) Wirth T., Hirt U.H. Synthesis. 1999;1271-1287 (i) Ochiai M. Chem. Hypervalent. Compd. 1999;359-387 (j) Koser G.F. Aldrichim.d Acta. 34:2001;89-102 (k) Zhdankin V.V., Stang P.J. Chem. Rev. 102:2002;2523-2584.
7. For general reviews on polyvalent iodine compounds, see: (a) Varvoglis A. Chem. Soc. Rev. 10:1981;377-407 (b) Moriarty R.M., Vaid R.K. Synthesis. 1990;431-447 (c) Varvoglis A. The Organic Chemistry of Polycoordinated Iodine. 1992;VCH, New York, (d) Stang P.J., Zhdankin V.V. Chem. Rev. 96:1996;1123-1178 (e) Varvoglis A. Hypervalent Iodine in Organic Synthesis. 1997;Academic, San Diego, (f) Kitamura T., Fujiwara Y. Org. Prep. Proced. Int. 29:1997;409-458 (g) Varvoglis A. Tetrahedron. 53:1997;1179-1255 (h) Wirth T., Hirt U.H. Synthesis. 1999;1271-1287 (i) Ochiai M. Chem. Hypervalent. Compd. 1999;359-387 (j) Koser G.F. Aldrichim.d Acta. 34:2001;89-102 (k) Zhdankin V.V., Stang P.J. Chem. Rev. 102:2002;2523-2584.
8. For general reviews on polyvalent iodine compounds, see: (a) Varvoglis A. Chem. Soc. Rev. 10:1981;377-407 (b) Moriarty R.M., Vaid R.K. Synthesis. 1990;431-447 (c) Varvoglis A. The Organic Chemistry of Polycoordinated Iodine. 1992;VCH, New York, (d) Stang P.J., Zhdankin V.V. Chem. Rev. 96:1996;1123-1178 (e) Varvoglis A. Hypervalent Iodine in Organic Synthesis. 1997;Academic, San Diego, (f) Kitamura T., Fujiwara Y. Org. Prep. Proced. Int. 29:1997;409-458 (g) Varvoglis A. Tetrahedron. 53:1997;1179-1255 (h) Wirth T., Hirt U.H. Synthesis. 1999;1271-1287 (i) Ochiai M. Chem. Hypervalent. Compd. 1999;359-387 (j) Koser G.F. Aldrichim.d Acta. 34:2001;89-102 (k) Zhdankin V.V., Stang P.J. Chem. Rev. 102:2002;2523-2584.
9. For general reviews on polyvalent iodine compounds, see: (a) Varvoglis A. Chem. Soc. Rev. 10:1981;377-407 (b) Moriarty R.M., Vaid R.K. Synthesis. 1990;431-447 (c) Varvoglis A. The Organic Chemistry of Polycoordinated Iodine. 1992;VCH, New York, (d) Stang P.J., Zhdankin V.V. Chem. Rev. 96:1996;1123-1178 (e) Varvoglis A. Hypervalent Iodine in Organic Synthesis. 1997;Academic, San Diego, (f) Kitamura T., Fujiwara Y. Org. Prep. Proced. Int. 29:1997;409-458 (g) Varvoglis A. Tetrahedron. 53:1997;1179-1255 (h) Wirth T., Hirt U.H. Synthesis. 1999;1271-1287 (i) Ochiai M. Chem. Hypervalent. Compd. 1999;359-387 (j) Koser G.F. Aldrichim.d Acta. 34:2001;89-102 (k) Zhdankin V.V., Stang P.J. Chem. Rev. 102:2002;2523-2584.
10. For general reviews on polyvalent iodine compounds, see: (a) Varvoglis A. Chem. Soc. Rev. 10:1981;377-407 (b) Moriarty R.M., Vaid R.K. Synthesis. 1990;431-447 (c) Varvoglis A. The Organic Chemistry of Polycoordinated Iodine. 1992;VCH, New York, (d) Stang P.J., Zhdankin V.V. Chem. Rev. 96:1996;1123-1178 (e) Varvoglis A. Hypervalent Iodine in Organic Synthesis. 1997;Academic, San Diego, (f) Kitamura T., Fujiwara Y. Org. Prep. Proced. Int. 29:1997;409-458 (g) Varvoglis A. Tetrahedron. 53:1997;1179-1255 (h) Wirth T., Hirt U.H. Synthesis. 1999;1271-1287 (i) Ochiai M. Chem. Hypervalent. Compd. 1999;359-387 (j) Koser G.F. Aldrichim.d Acta. 34:2001;89-102 (k) Zhdankin V.V., Stang P.J. Chem. Rev. 102:2002;2523-2584.
11. For general reviews on polyvalent iodine compounds, see: (a) Varvoglis A. Chem. Soc. Rev. 10:1981;377-407 (b) Moriarty R.M., Vaid R.K. Synthesis. 1990;431-447 (c) Varvoglis A. The Organic Chemistry of Polycoordinated Iodine. 1992;VCH, New York, (d) Stang P.J., Zhdankin V.V. Chem. Rev. 96:1996;1123-1178 (e) Varvoglis A. Hypervalent Iodine in Organic Synthesis. 1997;Academic, San Diego, (f) Kitamura T., Fujiwara Y. Org. Prep. Proced. Int. 29:1997;409-458 (g) Varvoglis A. Tetrahedron. 53:1997;1179-1255 (h) Wirth T., Hirt U.H. Synthesis. 1999;1271-1287 (i) Ochiai M. Chem. Hypervalent. Compd. 1999;359-387 (j) Koser G.F. Aldrichim.d Acta. 34:2001;89-102 (k) Zhdankin V.V., Stang P.J. Chem. Rev. 102:2002;2523-2584.
12. Moreno I., Tellitu I., Etayo J., SanMartin R., Domínguez E. Tetrahedron. 57:2001;5403-5411.
13. (a) Moreno I., Tellitu I., SanMartin R., Badía D., Carrillo L., Domínguez E. Tetrahedron Lett. 40:1999;5067-5070
14. (b) Moreno I., Tellitu I., SanMartin R., Domínguez E. Synlett. 2001;1161-1163
15. (c) Moreno I., Tellitu I., Domínguez E., SanMartin R. Eur. J. Org. Chem. 2002;2126-2135.
16. A review about the applications of hypervalent iodine reagents in oxidative coupling reactions in: Moreno I., Tellitu I., Herrero M.T., SanMartin R., Domínguez E. Curr. Org. Chem. 4:2002;1433-1452.
17. Kikugawa Y., Kawase M. Chem. Lett. 1990;581-582.
18. (a) Herrero M.T., Tellitu I., Hernández S., Domínguez E., Moreno I., SanMartin R. ARKIVOC. 2002;31-37
19. (b) Herrero M.T., Tellitu I., Domínguez E., Hernández S., Moreno I., SanMartin R. Tetrahedron. 58:2002;8581-8589.
20. Serna S., Tellitu I., Domínguez E., Moreno I., SanMartin R. Tetrahedron Lett. 44:2003;3483-3486.
21. Fraser A.D. Ther. Drug Monit. 20:1998;481-489.
22. Sternbach L.H. J. Med. Chem. 22:1979;1-7.
23. Kornecki E., Ehrlich Y.H., Lenox R.H. Science. 226:1984;1454-1456.
24. Hsu M.-C., Schutt A.D., Hooly M., Slice L.W., Sherman M.I., Richman D.D., Potash M.J., Volsky D.J. Science. 254:1991;1799-1802.
25. Pauwels R., Andries K., Desmyter J., Schols D., Kukla M.J., Breslin H.J., Raeymaeckers A., Van Gelder J., Woestenborghs R., Heykants J., Schellekens K., Jannsen M.A.C., Clerq E.D., Janssen P.A.J. Nature (London). 343:1990;470-474.
26. Some review articles on the synthesis of 1,4-benzodiazepines: (a) Joshi B., Chauhan M. Ind. J. Heterocycl. Chem. 6:1996;157-164 (b) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;431-543 (c) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;545-629 (d) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;631-848 (e) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;849-946 (f) Bunin B.A., Plunkett M. J. Methods Enzymol. 267:1996;448-465.
27. Some review articles on the synthesis of 1,4-benzodiazepines: (a) Joshi B., Chauhan M. Ind. J. Heterocycl. Chem. 6:1996;157-164 (b) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;431-543 (c) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;545-629 (d) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;631-848 (e) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;849-946 (f) Bunin B.A., Plunkett M. J. Methods Enzymol. 267:1996;448-465.
28. Some review articles on the synthesis of 1,4-benzodiazepines: (a) Joshi B., Chauhan M. Ind. J. Heterocycl. Chem. 6:1996;157-164 (b) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;431-543 (c) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;545-629 (d) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;631-848 (e) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;849-946 (f) Bunin B.A., Plunkett M. J. Methods Enzymol. 267:1996;448-465.
29. Some review articles on the synthesis of 1,4-benzodiazepines: (a) Joshi B., Chauhan M. Ind. J. Heterocycl. Chem. 6:1996;157-164 (b) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;431-543 (c) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;545-629 (d) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;631-848 (e) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;849-946 (f) Bunin B.A., Plunkett M. J. Methods Enzymol. 267:1996;448-465.
30. Some review articles on the synthesis of 1,4-benzodiazepines: (a) Joshi B., Chauhan M. Ind. J. Heterocycl. Chem. 6:1996;157-164 (b) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;431-543 (c) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;545-629 (d) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;631-848 (e) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;849-946 (f) Bunin B.A., Plunkett M. J. Methods Enzymol. 267:1996;448-465.
31. Some review articles on the synthesis of 1,4-benzodiazepines: (a) Joshi B., Chauhan M. Ind. J. Heterocycl. Chem. 6:1996;157-164 (b) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;431-543 (c) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;545-629 (d) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;631-848 (e) Walser A., Fryer R.I. Chem. Heterocycl. Compd. 50:1991;849-946 (f) Bunin B.A., Plunkett M. J. Methods Enzymol. 267:1996;448-465.
32. In 1984, Kornecki et al. found that triazolobenzodiazepines, such as alprazolam or triazolam, showed anti-PAF activities: Kornecki E., Ehrlich Y.H., Lenox R.H. Science. 226:1984;1454-1456.
33. Some thieno-fused diazepines have shown antitumor activity. See for example: Lisowski V., Fabis F., Pierre A., Caignard D.H., Renard P., Rault S. J. Enzym. Inhib. Med. Chem. 17:2002;403-407.
34. The antitumor and antibiotic activities of some pyrrolo[1,4]benzodiazepines is described in: Puvvada M.S., Forrow S.A., Hartley J.A., Stephenson P., Gibson I., Jenkins T.C., Thurston D.E. Biochemistry. 36:1997;2478-2484 (b) Thurston D.E., Bose D.S., Howard P.W., Jenkins T., Leoni A., Baraldi P.G., Guiotto A., Cacciari B., Kelland L.R., Folope M.P., Rault S. J. Med. Chem. 42:1999;1951-1964.
35. The antitumor and antibiotic activities of some pyrrolo[1,4]benzodiazepines is described in: Puvvada M.S., Forrow S.A., Hartley J.A., Stephenson P., Gibson I., Jenkins T.C., Thurston D.E. Biochemistry. 36:1997;2478-2484 (b) Thurston D.E., Bose D.S., Howard P.W., Jenkins T., Leoni A., Baraldi P.G., Guiotto A., Cacciari B., Kelland L.R., Folope M.P., Rault S. J. Med. Chem. 42:1999;1951-1964.
36. The analgesic activity of some indolo-fused diazepin derivatives is described in: Fegeler, J. J.; Gardenhire, E. M.; Helsley, G. C. US 4897392, 1990; Chem. Abstr. 113, 40741.
37. See for example: Fiakpvi C.Y., Phillips O.A., Murthy K.S.K., Knavs E.E. Drug Des. Discovery. 10:1993;45-55.
38. Herrero M.T., Tellitu I., Domínguez E., Moreno I., SanMartin R. Tetrahedron Lett. 43:2002;8273-8275.
39. (a) Ku T.W., Ali F.E., Bondinell W.E. Tetrahedron Lett. 38:1997;3131-3134
40. (b) Karp G.M. J. Org. Chem. 60:1995;5814-5819
41. (c) Blackburn B.K., Lee A., Baier M., Kohl B., Olivero A.G., Matamoros R., Robarge K.D., McDowell R.S. J. Med. Chem. 40:1997;717-729.
42. For an alternative synthesis of 4b, including spectroscopic information, see: Buckley T.F. III, Rapoport H. J. Am. Chem. Soc. 103:1981;6157-6163.
43. This substrate was prepared following standard procedures by reductive amination of benzaldehyde with alanine methyl ester. Spectroscopic data of compound 3b can be found in: Szilágyi L., Györgydeák Z. J. Am. Chem. Soc. 101:1979;427-432.
44. 2O was employed for the hydrolysis of ester (S)-7b to avoid, as detected under other conditions, racemization at this stage.
45. (a) Huang W., Moody D.E. J. Anal. Toxicol. 19:1995;333-342
46. (b) Ishizaki J., Yokogawa K., Nakashima E., Ichimura F. J. Pharm. Pharmacol. 49:1997;768-772
47. (c) Verstraete A.G., Belpaire F.M., Leroux-Roels G.G. J. Anal. Toxicol. 22:1998;27-32.
48. (a) Weber K.H., Sirrenberg W., Spohn O., Daniel H. Arzneim.-Forsch. 36:1986;518-521
49. (b) Van der Lan J.W., Eigeman L., Jansen vant Land C. Eur. Neuropsychopharmacol. 2:1992;425-431.
50. Catabay A., Taniguchi M., Jinno K., Pesek J.J., Williamsen E. Chromatography. 19:1998;108-111.
51. These antitumoral antiobiotics have been isolated from Streptomyces species. Their therapeutic activity is due to their ability to combine with specific sequences of DNA. See for example: Mountzouris J.A., Wang J.J., Thurston D.E., Hurley L.H. J. Med. Chem. 37:1994;3132-3140.
52. 2 as additive only procured traces of the bicyclic product 6c.
53. 2 complete degradation of the starting material was observed. Since, in this case, the use of trifluoroethanol made a significant improvement, the transformation of amide 5c into diazepine 6c was also attempted but with no success.